Advertisement
Journal Home
Search for

Volume 197, Issue 3, Supplement, Pages S96-S100 (September 2007)


View previous. 14 of 20 View next.

Cesarean delivery for HIV-infected women: recommendations and controversies

Denise J. Jamieson, MD, MPH1Corresponding Author Informationemail address, Jennifer S. Read, MD, MPH2, Athena P. Kourtis, MD, PhD, MPH1, Tonji M. Durant, PhD3, Margaret A. Lampe, RN, MPH3, Kenneth L. Dominguez, MD, MPH3

Received 15 December 2006; accepted 26 February 2007.

Two studies that were published in 1999 demonstrated that cesarean delivery before labor and before the rupture of membranes (elective cesarean delivery) reduces the risk of mother-to-child transmission of the human immunodeficiency virus (HIV). On the basis of these results, the American College of Obstetricians and Gynecologists and the US Public Health Service recommend that HIV-infected pregnant women with plasma viral loads of >1000 copies per milliliter be counseled regarding the benefits of elective cesarean delivery. Since the release of these guidelines, the cesarean delivery rate among HIV-infected women in the United States has increased dramatically. Major postpartum morbidity is uncommon, and cesarean delivery among HIV-infected women is relatively safe and cost-effective. However, a number of important questions remain unanswered, including whether cesarean delivery has a role among HIV-infected women with low plasma viral loads or who receive combination antiretroviral regimens.

1 Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA

2 Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD

3 Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, GA.

Corresponding Author InformationReprints: Denise J. Jamieson, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Hwy, Mallstop K-34, Atlanta, Georgia 30333.

 The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Department of Health and Human Services.

PII: S0002-9378(07)00270-0

doi:10.1016/j.ajog.2007.02.034


View previous. 14 of 20 View next.

Advertisement